Efficacy and safety results in participants co-infected with HIV from TB-PRACTECAL Clinical Trial

被引:0
|
作者
Motta, I. [1 ]
Berry, C. [1 ]
Kazounis, E. [1 ]
Dodd, M. [2 ]
Fielding, K. [2 ]
Nyang'wa, B. -T. [3 ]
机构
[1] Med Sans Frontieres UK, London, England
[2] London Sch Hyg & Trop Med, London, England
[3] Med Sans Frontieres Holland, Amsterdam, Netherlands
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
OAB0402
引用
收藏
页码:15 / 16
页数:2
相关论文
共 50 条
  • [1] Safety and efficacy of dolutegravir-based ART in TB/HIV co-infected adults at week 48
    Dooley, K.
    Kaplan, R.
    Mwelase, T.
    Grinsztejn, B.
    Ticona, E.
    Lacerda, M.
    Sued, O.
    Belonosova, E.
    Ait-Khaled, M.
    Angelis, K.
    Brown, D.
    Singh, R.
    Talarico, C.
    Tenorio, A.
    Keegan, M.
    Aboud, M.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21 : 10 - 10
  • [2] Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB: HIV study
    Efsen, A. M. W.
    Schultze, A.
    Miller, R. F.
    Panteleev, A.
    Skrahin, A.
    Podlekareva, D. N.
    Miro, J. M.
    Girardi, E.
    Furrer, H.
    Losso, M. H.
    Toibaro, J.
    Cayla, J. A.
    Mocroft, A.
    Lundgren, J. D.
    Post, F. A.
    Kirk, O.
    JOURNAL OF INFECTION, 2018, 76 (01) : 44 - 54
  • [3] Hepatic Safety of High-Dose Rifampicin for Tuberculosis Treatment in TB/HIV Co-infected Patients: A Randomized Clinical Trial
    Sanni, Sekossounon
    Wachinou, Ablo Prudence
    Merle, Corinne Simone Colette
    Bekou, Kossi Wilfried
    Esse, Marius
    Gossa, Severin
    Gomina, Khalil
    Baba-Moussa, Lamine
    Affolabi, Dissou
    ARCHIVES OF PHARMACY PRACTICE, 2021, 12 (03) : 66 - 72
  • [4] Population pharmacokinetics and pharmacodynamics of investigational regimens' drugs in the TB-PRACTECAL clinical trial (the PRACTECAL-PKPD study): a prospective nested study protocol in a randomised controlled trial
    Nyang'wa, Bern-Thomas
    Kloprogge, Frank
    Moore, David A. J.
    Bustinduy, Amaya
    Motta, Ilaria
    Berry, Catherine
    Davies, Geraint R.
    BMJ OPEN, 2021, 11 (09):
  • [5] Treatment challenges in Co-infected HIV and TB children
    Manosuthi, Weerawat
    Wongsawat, Jurai
    INDIAN PEDIATRICS, 2011, 48 (12) : 937 - 938
  • [6] Treatment challenges in Co-infected HIV and TB children
    Weerawat Manosuthi
    Jurai Wongsawat
    Indian Pediatrics, 2011, 48 : 937 - 938
  • [7] Epidemiologic and Immunologic Characters of HIV/TB Co-infected Patients
    Almasi, F.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : E483 - E483
  • [8] A randomized multicentre open-label trial to estimate the efficacy and safety of two doses of raltegravir (RAL) to efavirenz (EFV) for the treatment of HIV-TB co-infected patients: results of the ANRS 12 180 Reflate TB trial
    Grinsztejn, B.
    De Castro, N.
    Arnold, V.
    Veloso, V.
    Morgado, M.
    Pilotto, J. H.
    Brites, C.
    Madruga, J. V.
    Barcellos, N.
    Riegel Santos, B.
    Vorsatz, C.
    Grondin, C.
    Santini-Oliveira, M.
    Patey, O.
    Delaugerre, C.
    Chene, G.
    Molina, J-M.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 57 - 57
  • [9] Abandonment of tuberculosis treatment among patinets co-infected with TB/HIV
    Ataide Rodrigues, Ivaneide Leal
    Monteiro, Larissa Lima
    Barros Pacheco, Regia Hevelline
    Dias da Silva, Silvio Eder
    REVISTA DA ESCOLA DE ENFERMAGEM DA USP, 2010, 44 (02) : 380 - 384
  • [10] Antiretroviral and Antituberculosis Therapy in HIV-TB Co-Infected Children
    Slogrove, Amy L.
    Rabie, Helena
    Cotton, Mark F.
    CURRENT PEDIATRIC REVIEWS, 2011, 7 (03) : 173 - 179